Novasearch AG
Records under this name other than patents Novasearch AG holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 5 of 5 · Back to Novasearch AG
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 6,384,042 | Systemic Use of 5-HT3 Receptor Antagonists Against Rheumatic Inflammatory Processes Term ended Term ended Feb 16, 2020 · High confidence | Term ended | Term ended Feb 16, 2020 | High confidence |
| US 6,462,065 | Use of 5-HT(3) Receptor Antagonists for Treating Musculoeskeletal Diseases Term ended Term ended Feb 16, 2020 · High confidence | Term ended | Term ended Feb 16, 2020 | High confidence |
| US 7,393,857 | Use of 5-HT3 receptor antagonists for treating musculoskeletal diseases Lapsed on the fee record Ended Jul 1, 2016 · From the USPTO record | Lapsed on the fee record | Ended Jul 1, 2016 | From the USPTO record |
| US 5,773,436 | Use of serotonin antagonists for treating fibromyalgia Term ended Term ended no later than Jun 30, 2018 · Low confidence | Term ended | Term ended no later than Jun 30, 2018 | Low confidence |
| US 5,985,866 | Use of serotonin antagonists for treating fibromyalgia Term ended Term ended no later than Nov 16, 2019 · Low confidence | Term ended | Term ended no later than Nov 16, 2019 | Low confidence |